<!DOCTYPE html>
<html>
  <head>
    <meta charset="UTF-8">
  	<meta name="viewport" content="width=device-width,initial-scale=1">
    <title>Medicamentum</title>
    <link rel="stylesheet" href="assets/css/reset.css" type="text/css">
  	<link rel="stylesheet" href="assets/css/main.css" type="text/css">
  	<script src="assets/js/jquery-3.4.1.min.js"></script>
  	<script src="assets/js/main.js"></script>
  </head>
  <body>
    <!-- DO NOT REMOVE ABOVE -->
    <!-- start here -->

 <!-- start title -->
<div class="container title">
    Medicamentum
</div>  
<!-- end title -->



<!-- start scientist -->
  <div class="scientist">
    <div class="item w1of2">
     <img src="assets/images/scientist.png"> </div>
     <div class="overlay1">
       <div class="text1"> Healthcare is becoming a data intensive environment where a huge amount of data is both produced and consumed. In this context, digital medicine is assuming an increasingly important role </div>
     </div>
    </div>
<!-- end scientist -->



<!-- start research -->
<div class="container research">
  <div class="item w1of2">
    <img src="assets/images/research.png"> </div>
    <div class="overlay2">
       <div class="text2"> The first emergence of a swallowable electronic device was in 1957, this device used radio frequency to transmit temperature and pressure readings.The field lay stagnant until technology caught up with invention in the 1990s. The first digital pill to be approved by the United States Food and Drug Administration (FDA), a version of aripiprazole (Abilify) manufactured by Otsuka Pharmaceutical, was approved in November 2017.[ </div>
  </div>
</div>
<!-- end research -->



<!-- start digital pill -->

<!-- end digital pill -->



<!-- start sick person -->
<div class="container sick">
  <div class="item w1of2">
    <img src="assets/images/sick.png">
    <div class="overlay4">
       <div class="text4"> The drug is taken by people with schizophrenia. People with the condition tend to have problems with adherence, and the digital pill could help with that; however some people with schizophernia have paranoia which the digital pill could make worse. </div>
  </div>
</div>
<!-- end sick person -->



<!-- start hospital -->
<div class="container hospital">
  <div class="item w1of2">
    <img src="assets/images/hospital.png">
    <div class="overlay5">
       <div class="text5"> Patients who agree to take the digital medication, a version of the antipsychotic Abilify, can sign consent forms allowing their doctors and up to four other people, including family members, to receive electronic data showing the date and time pills are ingested. </div>
  </div>
</div>
<!-- end hospital -->



<!-- start body -->
<div class="container body">
  <div class="item w1of2">
    <img src="assets/images/body.png">
    <div class="overlay6">
       <div class="text6"> This digital pill's sensor, developed by Proteus Digital Health, is activated by acid in the stomach, and generates an electrical signal that is picked up by a patch worn on the ribcage; the patch in turn forwards information to a smartphone app. </div>
  </div>
</div>
<!-- end body -->



<!-- start monitor -->
<div class="container monitor">
  <div class="item w1of2">
    <img src="assets/images/monitor.png">
    <div class="overlay7">
       <div class="text7"> Although voluntary, the technology is still likely to prompt questions about privacy and whether patients might feel pressure to take medication in a form their doctors can monitor. </div>
  </div> 
</div>
<!-- end monitor -->



<!-- start credit -->
<div class="container credit">
    CC BY-NC-SA 4.0 Shania Roseline 2020
  </div>
<!-- end credit -->




    <!-- DO NOT REMOVE BELOW -->
    <!-- end here -->
  </body>
</html>
